An innovative small-molecule drug that targets fat cells directly without affecting the central nervous system
Visible improvements in skin or hair appearance typically show up within 6-8 weeks of consistent use with topical GHK-Cu
It establishes a robust yet adaptable coordination with Cu(II) ions, utilizing the amino group of glycine, the imidazole nitrogen of histidine, and the -amino group of lysine
In addition, it can lead to a decrease in serum levels of IL-1 and rheumatoid factor (RF), an increase in serum levels of IL-6, IL-13, IL-15, IL-23, TNF-, and IFN-, and the activation of NK cells, which can often lead to autoimmune diseases and autoimmune complications of DPA treatment (see Figure 3) [9,170,190,191,192]
Some have relabeled it as Pentadecapeptide Aringate or PDA (changing the acetate to an arginate) and are prescribing it for subcutaneous administration that way, while the confusion about its status has led to a vibrant oral capsule market for BPC in what appears to be a grey area of legality
Peptides have become the latest obsession on Instagram, TikTok, and YouTube, where influencers rave about injectable stacks that promise fat loss, faster recovery, better sleep, and glowing skin